Ads
related to: Acute Myeloid Leukemia- CML Perspectives
Hear From CML Experts And
Access CML Resources.
- Third Line CML
Get CML Information And Learn
More About CML In Later Lines.
- CML Perspectives
Search results
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 36 minutes agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
WTNH-TV New Haven· 2 days agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel...
Why Bio-Path Stock Is Soaring - Bio-Path Hldgs (NASDAQ:BPTH)
Benzinga· 7 days agoBPTH shares are trading higher Thursday after the company announced the completion of its second...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 hour agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will
Potential new treatment strategy for aggressive leukemia
Medical Xpress· 7 days agoIn findings published in Nature Cancer, researchers reveal that blocking these oxygen-sensing enzymes can significantly halt acute myeloid leukemia ...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 17 hours agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
FDA grants breakthrough status for Kura Oncology's AML drug candicate By Investing.com
Investing.com· 3 days agoFood and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to its drug...
Moleculin's acute myeloid leukemia treatment gets EMA's orphan drug designation
Seeking Alpha· 7 days agoMoleculin Biotech's Annamycin receives Orphan Drug Designation from the European Medicines Agency for AML treatment, expanding its potential market reach.
CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers
MedPage Today· 1 day agoA strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical...
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Zacks via Yahoo Finance· 6 days agoBio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its...
Ads
related to: Acute Myeloid Leukemia
